Sign in
Taking people in United StatesNo phase

Leveraging Regulatory Flexibility for Methadone Take-Home Dosing to Improve Retention in Treatment for Opioid Use Disorder

Key facts

Who runs it
NYU Langone Health
Where
Buffalo, New York, and Storrs, United StatesSee the 4 sites
Trial code
Status
Recruiting
People taking part
318 people, planned
Started
27 Jan 2023
Expected to end
31 Aug 2027
Type of study
Interventional, 6 groups
Treatments tested
  • Clinic-Level Multidimensional Intervention
Record updated
12 August 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Clinic staff inclusion will include anyone who works at the 10 clinics that the OASAS client data system generates from the quantitative analysis in year one. In years 2-5, clinics chosen by the OASAS client data system will be placed into six cohorts. Only staff from these clinics will be eligible
  • Patient inclusion will include anyone aged 18 or older who has been receiving take-home methadone for at least 30 days

Who cannot take part

  • There are no exclusion criteria related to sex/gender to increase the generalizability of the findings. The investigators will note include children in this study because the treatment system that we are examining largely excludes adolescents and younger children

Where in United States

  • University at BuffaloBuffalo, United StatesContact: Charles Neighbors, PhDTaking people
  • NYU Langone HealthNew York, United StatesContact: Charles Neighbors, PhD (principal investigator)Taking people
  • Weill Cornell Medical CollegeNew York, United StatesContact: Yuhua Bao (principal investigator)Taking people
  • University of ConnecticutStorrs, United StatesContact: Megan O'Grady, Ph.D. (principal investigator)Taking people

About the trial

What the trial wants to find out

Using a stepped-wedge randomized controlled trial, the study will test whether a clinic-level multidimensional intervention conducted in 36 opioid treatment programs (OTPs) will improve clinical decision making, regulatory confusion, legal liability concerns, capacity for clinical practice change, and financial barriers to take- home dosing (THD) for methadone as compared to treatment as usual.

The 6 groups in the trial

  • Cohort 1Treatment being tested

    6 of the 36 recruited opioid treatment programs (OTPs) will be enrolled in group 1. Group 1 will start the six-month intervention at Baseline and end at Month 6.

    Treatment: Clinic-Level Multidimensional Intervention

  • Cohort 2Treatment being tested

    6 of the 36 recruited opioid treatment programs (OTPs) will be enrolled in Cohort 2. Cohort 2 will start the six-month intervention at Month 6 and end at Month 12.

    Treatment: Clinic-Level Multidimensional Intervention

  • Cohort 3Treatment being tested

    6 of the 36 recruited opioid treatment programs (OTPs) will be enrolled in Cohort 3. Cohort 3 will start the six-month intervention at Month 12 and end at Month 18.

    Treatment: Clinic-Level Multidimensional Intervention

  • Cohort 4Treatment being tested

    6 of the 36 recruited opioid treatment programs (OTPs) will be enrolled in Cohort 4. Cohort 4 will start the six-month intervention at Month 18 and end at Month 24.

    Treatment: Clinic-Level Multidimensional Intervention

  • Cohort 5Treatment being tested

    6 of the 36 recruited opioid treatment programs (OTPs) will be enrolled in Cohort 5. Cohort 5 will start the six-month intervention at Month 24 and end at Month 30.

    Treatment: Clinic-Level Multidimensional Intervention

  • Cohort 6Treatment being tested

    6 of the 36 recruited opioid treatment programs (OTPs) will be enrolled in Cohort 5. Cohort 5 will start the six-month intervention at Month 30 and end at Month 36.

    Treatment: Clinic-Level Multidimensional Intervention

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Leveraging Regulatory Flexibility for Methadone Take-Home Dosing to Improve Retention in Treatment for Opioid Use Disorder: A Stepped-Wedge Randomized Trial to Facilitate Clinic Level Changes
Record updated
12 August 2026